Stemtech Corporation
Stemtech Corporation STEK Peers
See (STEK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| STEK | $0.04 | +27.54% | 5.24M | -0.78 | -$0.05 | N/A |
| MKGAF | $136.20 | +3.81% | 59.22B | 19.05 | $7.15 | +1.64% |
| MKKGY | $26.45 | +1.62% | 57.56B | 18.50 | $1.43 | +1.44% |
| HLNCF | $5.49 | +4.37% | 49.52B | 26.14 | $0.21 | +1.97% |
| TKPHF | $26.30 | N/A | 41.39B | 57.17 | $0.46 | +5.06% |
| IPSEY | $29.34 | +1.09% | 38.83B | 24.66 | $1.19 | +1.08% |
| SDZNY | $48.05 | +1.90% | 20.70B | -2402.50 | -$0.02 | +0.85% |
| TEVJF | $16.11 | N/A | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $7.84 | +1.98% | 13.34B | 11.53 | $0.68 | +0.90% |
Stock Comparison
STEK vs MKGAF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, MKGAF has a market cap of 59.22B. Regarding current trading prices, STEK is priced at $0.04, while MKGAF trades at $136.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas MKGAF's P/E ratio is 19.05. In terms of profitability, STEK's ROE is +1.38%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, STEK is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs MKKGY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, MKKGY has a market cap of 57.56B. Regarding current trading prices, STEK is priced at $0.04, while MKKGY trades at $26.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas MKKGY's P/E ratio is 18.50. In terms of profitability, STEK's ROE is +1.38%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, STEK is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HLNCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HLNCF has a market cap of 49.52B. Regarding current trading prices, STEK is priced at $0.04, while HLNCF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HLNCF's P/E ratio is 26.14. In terms of profitability, STEK's ROE is +1.38%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TKPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TKPHF has a market cap of 41.39B. Regarding current trading prices, STEK is priced at $0.04, while TKPHF trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TKPHF's P/E ratio is 57.17. In terms of profitability, STEK's ROE is +1.38%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, STEK is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs IPSEY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, IPSEY has a market cap of 38.83B. Regarding current trading prices, STEK is priced at $0.04, while IPSEY trades at $29.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas IPSEY's P/E ratio is 24.66. In terms of profitability, STEK's ROE is +1.38%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, STEK is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SDZNY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SDZNY has a market cap of 20.70B. Regarding current trading prices, STEK is priced at $0.04, while SDZNY trades at $48.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SDZNY's P/E ratio is -2402.50. In terms of profitability, STEK's ROE is +1.38%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, STEK is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TEVJF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, STEK is priced at $0.04, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, STEK's ROE is +1.38%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, STEK is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ESALY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, STEK is priced at $0.04, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ESALY's P/E ratio is 20.54. In terms of profitability, STEK's ROE is +1.38%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, STEK is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SGIOY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SGIOY has a market cap of 13.34B. Regarding current trading prices, STEK is priced at $0.04, while SGIOY trades at $7.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SGIOY's P/E ratio is 11.53. In terms of profitability, STEK's ROE is +1.38%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, STEK is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SGIOF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, STEK is priced at $0.04, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SGIOF's P/E ratio is 11.18. In terms of profitability, STEK's ROE is +1.38%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, STEK is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs BIOVF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, STEK is priced at $0.04, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas BIOVF's P/E ratio is 26.07. In terms of profitability, STEK's ROE is +1.38%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, STEK is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs IPSEF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, STEK is priced at $0.04, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, STEK's ROE is +1.38%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, STEK is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SFOSF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SFOSF has a market cap of 8.74B. Regarding current trading prices, STEK is priced at $0.04, while SFOSF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, STEK's ROE is +1.38%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, STEK is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ESAIY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ESAIY has a market cap of 7.49B. Regarding current trading prices, STEK is priced at $0.04, while ESAIY trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ESAIY's P/E ratio is 23.64. In terms of profitability, STEK's ROE is +1.38%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, STEK is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ESALF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ESALF has a market cap of 7.34B. Regarding current trading prices, STEK is priced at $0.04, while ESALF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ESALF's P/E ratio is 23.21. In terms of profitability, STEK's ROE is +1.38%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, STEK is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs GZPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GZPHF has a market cap of 6.34B. Regarding current trading prices, STEK is priced at $0.04, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, STEK's ROE is +1.38%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, STEK is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HKMPY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HKMPY has a market cap of 6.18B. Regarding current trading prices, STEK is priced at $0.04, while HKMPY trades at $56.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HKMPY's P/E ratio is 17.41. In terms of profitability, STEK's ROE is +1.38%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, STEK is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HKMPF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HKMPF has a market cap of 6.11B. Regarding current trading prices, STEK is priced at $0.04, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, STEK's ROE is +1.38%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, STEK is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs APNHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, STEK is priced at $0.04, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas APNHF's P/E ratio is 20.07. In terms of profitability, STEK's ROE is +1.38%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, STEK is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs WIBFF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, WIBFF has a market cap of 4.92B. Regarding current trading prices, STEK is priced at $0.04, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, STEK's ROE is +1.38%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, STEK is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs HLBBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, STEK is priced at $0.04, while HLBBF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, STEK's ROE is +1.38%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, STEK is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs LVZPF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LVZPF has a market cap of 3.99B. Regarding current trading prices, STEK is priced at $0.04, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, STEK's ROE is +1.38%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, STEK is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HLUBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HLUBF has a market cap of 3.50B. Regarding current trading prices, STEK is priced at $0.04, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, STEK's ROE is +1.38%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, STEK is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs INVVY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, STEK is priced at $0.04, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas INVVY's P/E ratio is -62.42. In terms of profitability, STEK's ROE is +1.38%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, STEK is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs APNHY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, APNHY has a market cap of 2.92B. Regarding current trading prices, STEK is priced at $0.04, while APNHY trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas APNHY's P/E ratio is 11.95. In terms of profitability, STEK's ROE is +1.38%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, STEK is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs IZQVF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, STEK is priced at $0.04, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, STEK's ROE is +1.38%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, STEK is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HYPMY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HYPMY has a market cap of 2.85B. Regarding current trading prices, STEK is priced at $0.04, while HYPMY trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HYPMY's P/E ratio is 20.50. In terms of profitability, STEK's ROE is +1.38%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, STEK is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HMDCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, STEK is priced at $0.04, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, STEK's ROE is +1.38%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, STEK is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs DNPUF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, STEK is priced at $0.04, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, STEK's ROE is +1.38%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, STEK is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ULIHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, STEK is priced at $0.04, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, STEK's ROE is +1.38%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, STEK is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HTSUF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, STEK is priced at $0.04, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HTSUF's P/E ratio is 15.91. In terms of profitability, STEK's ROE is +1.38%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, STEK is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs THCBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, THCBF has a market cap of 2.35B. Regarding current trading prices, STEK is priced at $0.04, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas THCBF's P/E ratio is -0.10. In terms of profitability, STEK's ROE is +1.38%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, STEK is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs CHSYF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, STEK is priced at $0.04, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, STEK's ROE is +1.38%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TSMRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, STEK is priced at $0.04, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, STEK's ROE is +1.38%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, STEK is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs DMPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, STEK is priced at $0.04, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas DMPHF's P/E ratio is 18.40. In terms of profitability, STEK's ROE is +1.38%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, STEK is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs LJUIF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, STEK is priced at $0.04, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, STEK's ROE is +1.38%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, STEK is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs LBTSF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, STEK is priced at $0.04, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, STEK's ROE is +1.38%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, STEK is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SHEZF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, STEK is priced at $0.04, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, STEK's ROE is +1.38%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, STEK is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs CHIZF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, STEK is priced at $0.04, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, STEK's ROE is +1.38%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, STEK is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SMDPY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, STEK is priced at $0.04, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SMDPY's P/E ratio is -1.35. In terms of profitability, STEK's ROE is +1.38%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, STEK is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs NPNKF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, NPNKF has a market cap of 1.59B. Regarding current trading prices, STEK is priced at $0.04, while NPNKF trades at $23.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas NPNKF's P/E ratio is 7.10. In terms of profitability, STEK's ROE is +1.38%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs NPPNY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, NPPNY has a market cap of 1.54B. Regarding current trading prices, STEK is priced at $0.04, while NPPNY trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas NPPNY's P/E ratio is 6.98. In terms of profitability, STEK's ROE is +1.38%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs KARBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, STEK is priced at $0.04, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas KARBF's P/E ratio is 262.50. In terms of profitability, STEK's ROE is +1.38%, compared to KARBF's ROE of N/A. Regarding short-term risk, STEK is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs YIHCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, YIHCF has a market cap of 1.49B. Regarding current trading prices, STEK is priced at $0.04, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, STEK's ROE is +1.38%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, STEK is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs EVOTF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, STEK is priced at $0.04, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, STEK's ROE is +1.38%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, STEK is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ARSUF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, STEK is priced at $0.04, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, STEK's ROE is +1.38%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, STEK is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs GTBIF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GTBIF has a market cap of 1.35B. Regarding current trading prices, STEK is priced at $0.04, while GTBIF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GTBIF's P/E ratio is 27.14. In terms of profitability, STEK's ROE is +1.38%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, STEK is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SWGHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, STEK is priced at $0.04, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SWGHF's P/E ratio is 16.00. In terms of profitability, STEK's ROE is +1.38%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, STEK is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs GNMLF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, STEK is priced at $0.04, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, STEK's ROE is +1.38%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, STEK is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs KKPCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, KKPCF has a market cap of 1.03B. Regarding current trading prices, STEK is priced at $0.04, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas KKPCF's P/E ratio is 10.76. In terms of profitability, STEK's ROE is +1.38%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, STEK is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs KSPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, STEK is priced at $0.04, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas KSPHF's P/E ratio is 12.42. In terms of profitability, STEK's ROE is +1.38%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, STEK is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CASBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CASBF has a market cap of 983.80M. Regarding current trading prices, STEK is priced at $0.04, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CASBF's P/E ratio is -15.24. In terms of profitability, STEK's ROE is +1.38%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, STEK is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs BIOGY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, BIOGY has a market cap of 905.20M. Regarding current trading prices, STEK is priced at $0.04, while BIOGY trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas BIOGY's P/E ratio is 29.96. In terms of profitability, STEK's ROE is +1.38%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, STEK is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs LVTTF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LVTTF has a market cap of 878.32M. Regarding current trading prices, STEK is priced at $0.04, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, STEK's ROE is +1.38%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, STEK is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs EVRRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, EVRRF has a market cap of 876.03M. Regarding current trading prices, STEK is priced at $0.04, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, STEK's ROE is +1.38%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, STEK is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TCNNF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TCNNF has a market cap of 852.21M. Regarding current trading prices, STEK is priced at $0.04, while TCNNF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TCNNF's P/E ratio is -5.65. In terms of profitability, STEK's ROE is +1.38%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, STEK is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs NRXCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, NRXCF has a market cap of 829.81M. Regarding current trading prices, STEK is priced at $0.04, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, STEK's ROE is +1.38%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, STEK is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TWAPF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, STEK is priced at $0.04, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TWAPF's P/E ratio is 6.30. In terms of profitability, STEK's ROE is +1.38%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CSWYF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, STEK is priced at $0.04, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, STEK's ROE is +1.38%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, STEK is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TRXPF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, STEK is priced at $0.04, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, STEK's ROE is +1.38%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, STEK is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SWDCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, STEK is priced at $0.04, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, STEK's ROE is +1.38%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, STEK is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs NIKA Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, NIKA has a market cap of 672.85M. Regarding current trading prices, STEK is priced at $0.04, while NIKA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas NIKA's P/E ratio is N/A. In terms of profitability, STEK's ROE is +1.38%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, STEK is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs CURLF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CURLF has a market cap of 660.37M. Regarding current trading prices, STEK is priced at $0.04, while CURLF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CURLF's P/E ratio is -2.65. In terms of profitability, STEK's ROE is +1.38%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, STEK is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs TRSSF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, STEK is priced at $0.04, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, STEK's ROE is +1.38%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, STEK is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ELTP Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ELTP has a market cap of 544.82M. Regarding current trading prices, STEK is priced at $0.04, while ELTP trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ELTP's P/E ratio is -25.50. In terms of profitability, STEK's ROE is +1.38%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, STEK is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CCHWF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, STEK is priced at $0.04, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, STEK's ROE is +1.38%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, STEK is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs SGFEF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SGFEF has a market cap of 517.72M. Regarding current trading prices, STEK is priced at $0.04, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SGFEF's P/E ratio is 23.35. In terms of profitability, STEK's ROE is +1.38%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, STEK is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs AIHLF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, STEK is priced at $0.04, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, STEK's ROE is +1.38%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, STEK is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs BOIRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, STEK is priced at $0.04, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, STEK's ROE is +1.38%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, STEK is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs PEXXF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, STEK is priced at $0.04, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, STEK's ROE is +1.38%, compared to PEXXF's ROE of N/A. Regarding short-term risk, STEK is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs SHPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, STEK is priced at $0.04, while SHPHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, STEK's ROE is +1.38%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, STEK is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs MITPF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, STEK is priced at $0.04, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas MITPF's P/E ratio is -3.05. In terms of profitability, STEK's ROE is +1.38%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, STEK is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs KHTRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, KHTRF has a market cap of 444.34M. Regarding current trading prices, STEK is priced at $0.04, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas KHTRF's P/E ratio is 63.71. In terms of profitability, STEK's ROE is +1.38%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, STEK is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs AGYTF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, STEK is priced at $0.04, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, STEK's ROE is +1.38%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, STEK is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs GLASF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GLASF has a market cap of 306.71M. Regarding current trading prices, STEK is priced at $0.04, while GLASF trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GLASF's P/E ratio is -68.40. In terms of profitability, STEK's ROE is +1.38%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, STEK is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs PKBFF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, PKBFF has a market cap of 285.89M. Regarding current trading prices, STEK is priced at $0.04, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, STEK's ROE is +1.38%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, STEK is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs BHCCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, STEK is priced at $0.04, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, STEK's ROE is +1.38%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, STEK is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CRLBF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CRLBF has a market cap of 245.83M. Regarding current trading prices, STEK is priced at $0.04, while CRLBF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CRLBF's P/E ratio is -3.31. In terms of profitability, STEK's ROE is +1.38%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, STEK is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs VRNOF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, VRNOF has a market cap of 243.78M. Regarding current trading prices, STEK is priced at $0.04, while VRNOF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas VRNOF's P/E ratio is -0.68. In terms of profitability, STEK's ROE is +1.38%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, STEK is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CPHRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CPHRF has a market cap of 229.50M. Regarding current trading prices, STEK is priced at $0.04, while CPHRF trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CPHRF's P/E ratio is 24.89. In terms of profitability, STEK's ROE is +1.38%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, STEK is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs PLNHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, STEK is priced at $0.04, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, STEK's ROE is +1.38%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, STEK is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HUMDF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, STEK is priced at $0.04, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, STEK's ROE is +1.38%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, STEK is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs COPHF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, STEK is priced at $0.04, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas COPHF's P/E ratio is -0.02. In terms of profitability, STEK's ROE is +1.38%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, STEK is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs STMH Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, STMH has a market cap of 123.98M. Regarding current trading prices, STEK is priced at $0.04, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas STMH's P/E ratio is N/A. In terms of profitability, STEK's ROE is +1.38%, compared to STMH's ROE of -2.75%. Regarding short-term risk, STEK is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs PHCUF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, PHCUF has a market cap of 115.12M. Regarding current trading prices, STEK is priced at $0.04, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas PHCUF's P/E ratio is 432.00. In terms of profitability, STEK's ROE is +1.38%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, STEK is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs LPCUF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, STEK is priced at $0.04, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, STEK's ROE is +1.38%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, STEK is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs CNVCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, STEK is priced at $0.04, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, STEK's ROE is +1.38%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, STEK is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HLTRF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, STEK is priced at $0.04, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HLTRF's P/E ratio is -5.65. In terms of profitability, STEK's ROE is +1.38%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, STEK is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs GRUSF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GRUSF has a market cap of 101.62M. Regarding current trading prices, STEK is priced at $0.04, while GRUSF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GRUSF's P/E ratio is -8.20. In terms of profitability, STEK's ROE is +1.38%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, STEK is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs BIOYF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, BIOYF has a market cap of 96.82M. Regarding current trading prices, STEK is priced at $0.04, while BIOYF trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas BIOYF's P/E ratio is 17.58. In terms of profitability, STEK's ROE is +1.38%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, STEK is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs HBRM Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, HBRM has a market cap of 96.30M. Regarding current trading prices, STEK is priced at $0.04, while HBRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas HBRM's P/E ratio is N/A. In terms of profitability, STEK's ROE is +1.38%, compared to HBRM's ROE of +0.08%. Regarding short-term risk, STEK is more volatile compared to HBRM. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs ABSCF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, STEK is priced at $0.04, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, STEK's ROE is +1.38%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, STEK is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs LOVFF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LOVFF has a market cap of 84.83M. Regarding current trading prices, STEK is priced at $0.04, while LOVFF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LOVFF's P/E ratio is 9.28. In terms of profitability, STEK's ROE is +1.38%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, STEK is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs GBLP Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, STEK is priced at $0.04, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas GBLP's P/E ratio is -0.67. In terms of profitability, STEK's ROE is +1.38%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, STEK is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs LRDSF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, LRDSF has a market cap of 82.80M. Regarding current trading prices, STEK is priced at $0.04, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, STEK's ROE is +1.38%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, STEK is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for STEK.
STEK vs CBWTF Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, CBWTF has a market cap of 81.41M. Regarding current trading prices, STEK is priced at $0.04, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas CBWTF's P/E ratio is -6.20. In terms of profitability, STEK's ROE is +1.38%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, STEK is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs PLNH Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, PLNH has a market cap of 78.09M. Regarding current trading prices, STEK is priced at $0.04, while PLNH trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas PLNH's P/E ratio is -1.50. In terms of profitability, STEK's ROE is +1.38%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, STEK is more volatile compared to PLNH. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs EOFBY Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, STEK is priced at $0.04, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, STEK's ROE is +1.38%, compared to EOFBY's ROE of N/A. Regarding short-term risk, STEK is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.
STEK vs AAWH Comparison
STEK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STEK stands at 5.24M. In comparison, AAWH has a market cap of 67.24M. Regarding current trading prices, STEK is priced at $0.04, while AAWH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STEK currently has a P/E ratio of -0.78, whereas AAWH's P/E ratio is -0.82. In terms of profitability, STEK's ROE is +1.38%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, STEK is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for STEK.